Alkem Laboratories Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Alkem Laboratories Ltd. on BSE

Load latest

Alkem Laboratories Ltd.

28 Oct 2025

5722.50

-0.05%

Company Update

Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

BSE India

With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we write to inform you that a conference call to discuss the Q2 and H1FY26 financial results will be held on Thursday, November 13, 2025 at 04.30 p.m. Please find attached herewith the conference call details.

pdf

Alkem Laboratories Ltd.

28 Oct 2025

5722.50

-0.05%

Company Update

Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

BSE India

pdf

Alkem Laboratories Ltd.

23 Oct 2025

5722.50

-0.05%

Board Meeting

Alkem Laboratories Ltd - 539523 - Board Meeting Intimation for Notice Of Meeting Of The Board …

BSE India

Alkem Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2025 ,inter alia, to consider and approve the Standalone and Consolidated Unaudited Financial Results of the Company for the quarter and half year ended 30th September, 2025.

pdf

Alkem Laboratories Ltd.

01 Oct 2025

5722.50

-0.05%

Company Update

Alkem Laboratories Ltd - 539523 - Announcement Under Regulation 30 Of SEBI LODR - Regulatory Order

BSE India

Pursuant to Regulation 30 read with SEBI LODR Regulations, this is to inform you that the Company has received an appeal order passed by statutory authority under the Goods and Services Tax Act, 2017. The relevant disclosure is enclosed herewith.

pdf

Alkem Laboratories Ltd.

26 Sep 2025

5722.50

-0.05%

Company Update

Alkem Laboratories Ltd - 539523 - Announcement Under Reg 30 (LODR)- Alkem Laboratories Limited Entered Into …

BSE India

This is to inform you that today i.e. 26th September, 2025, the Company has entered into a Business Transfer Agreement with Alkem Wellness Limited, a wholly owned subsidiary of the Company for transfer of the trade generics business as a going concern, on a slump sale basis, effective from 01st October, 2025.

pdf

Alkem Laboratories Ltd.

25 Sep 2025

5722.50

-0.05%

SAST

Alkem Laboratories Ltd - 539523 - Closure of Trading Window

BSE India

This is to inform you that the trading window will remain closed from 29th September, 2025 until the expiry of 48 hours after the date on which the Financial Results of the Company for the quarter and half year ended 30th September, 2025 are communicated to the Stock Exchanges.

pdf

Alkem Laboratories Ltd.

25 Sep 2025

5722.50

-0.05%

Company Update

Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Change in Management

BSE India

This is to inform you that Mr. Amit Ghare, a Senior Management Personnel has tendered his resignation from the services of the Company on account of personal commitments effective from 30th September, 2025. Accordingly, Mr. Amit Ghare shall cease to hold Senior Management Position of the Company effective from the said date i.e 30th September, 2025.

pdf

Alkem Laboratories Ltd.

24 Sep 2025

5722.50

-0.05%

Company Update

Alkem Laboratories Ltd - 539523 - Announcement Under Regulation 30 Of SEBI LODR - Regulatory Order

BSE India

Pursuant to Regulation 30 of SEBI LODR Regulations, this is to inform you that the Company has received an order passed by the statutory authority under the Goods and Services Tax Act, 2017. The relevant disclosure is enclosed herewith.

pdf

Alkem Laboratories Ltd.

22 Sep 2025

5722.50

-0.05%

Company Update

Alkem Laboratories Ltd - 539523 - Announcement Under Regulation 30 Of SEBI LODR - Regulatory Order

BSE India

Pursuant to Regulation 30 of SEBI LODR Regulation, 2015, this is to inform you that the Company has received an order passed by the statutory authority under the Goods and Services Tax Act, 2017. The relevant disclosure is enclosed herewith.

pdf

Alkem Laboratories Ltd.

22 Sep 2025

5722.50

-0.05%

Company Update

Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

This is to intimate you that Alkem Laboratories Limited (the 'Company') launches Pertuza, a pertuzumab biosimilar, in India for treatment of HER2-positive breast cancer. A press release in this regard is enclosed herewith.

pdf

Is Alkem Laboratories Ltd. worth buying?

140 Votes:

Buy 79.29%

Sell 14.29%

Hold 6.43%

RESEARCH REPORTS

Buy SEE REPORTS >

pdf

Buy SEE REPORTS >

pdf

New 52W High in past week

High volume today

Alkem Laboratories Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Alkem Laboratories Ltd. on BSE